← Browse by Condition
Medical Condition

locoregional recurrence

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05467891 Phase 2
Recruiting

Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer

Enrollment
200 pts
Location
United States
Sponsor
Oana Danciu
View Trial →